Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesEffect of alendronate on bone metabolic indices and bone mineral density in patients treated with high-dose glucocorticoid: A prospective study
Osteoporosis International, 11/25/09
Kaji H et al. – Alendronate was effective in suppressing bone resorption and subsequent BMD decrease at the lumbar spine in patients with high-dose GC treatment.
Methods- Examined prospective effects of daily 5 mg alendronate on bone metabolism and BMD in 20 patients with high-dose GC (at least 40 mg prednisolone/day) and compared to 34 high-dose GC-treated patients without alendronate
- Serum levels of calcium decreased at day 28 in alendronate group
- Urinary calcium excretion significantly increased after day 7 in both groups
- Increase in serum PTH level at day 7 in control group not observed in alendronate group, but PTH levels increased at day 28 and month 3 in alendronate group
- Bone turnover markers, the serum osteocalcin level decreased in both alendronate and control groups, but serum bone-type alkaline phosphatase levels did not show significant changes
- Although urinary type I collagen cross-linked N-telopeptide (NTX) level showed significant increases on days 7 and 28 in control group; such early increases in urinary NTX not observed in alendronate group
- Urinary NTX levels fell slowly in alendronate group significantly
- BMD at lumbar spine significantly decreased from month 1 in control group, whereas in alendronate group, BMD at lumbar spine maintained almost the same level at all time points observed
Today in Bone Metabolism...keeping you current
Receive free subspecialty "5-minute updates" via email
Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis
Osteoporosis International, 02/09/10
Effects of bone mineral density of the lumbar spine and prevalent vertebral fractures on the risk of immobility
Osteoporosis International, 02/09/10
Identifying and managing osteoporosis: An update
The Journal of Musculoskeletal Medicine, 02/08/10
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
An open-label pilot study evaluating by magnetic resonance imaging the potential for a disease-modifying effect of celecoxib compared to a modelized historical control cohort in the treatment of knee osteoarthritis
Seminars in Arthritis and Rheumatism, 02/09/10
Mycophenolate mofetil for localized scleroderma
International Journal of Clinical Rheumatology, 02/09/10
Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis
Osteoporosis International, 02/09/10
Article Search
Sponsor
Sponsor